Evidence map›Paper›PMID 35055194›Full record

ArticleInternational journal of molecular sciences2022

Synthesis, Crystallographic, Quantum Chemical, Antitumor, and Molecular Docking/Dynamic Studies of 4-Hydroxycoumarin-Neurotransmitter Derivatives.

Dušan S Dimić, Goran N Kaluđerović, Edina H Avdović, Dejan A Milenković, Marko N Živanović, Ivan Potočňák, Erika Samoľová, Milena S Dimitrijević, Luciano Saso, Zoran S Marković and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. The Therapeutic Potential ofMolecules (Basel, Switzerland) · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Antibacterial Activity ofMolecules (Basel, Switzerland) · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 5 countries.

Dušan S DimićFaculty of Physical Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia.ORCID 0000-0001-8127-5396
Goran N KaluđerovićDepartment of Engineering and Natural Sciences, University of Applied Sciences Merseburg, Eberhard-Leibnitz-Straße 2, DE-06217 Merseburg, Germany.ORCID 0000-0001-5168-1000
Edina H AvdovićDepartment of Science, Institute for Information Technologies, University of Kragujevac, Jovana Cvijića bb, 34000 Kragujevac, Serbia.ORCID 0000-0003-2473-9603
Dejan A MilenkovićDepartment of Science, Institute for Information Technologies, University of Kragujevac, Jovana Cvijića bb, 34000 Kragujevac, Serbia.ORCID 0000-0001-7083-2257
Marko N ŽivanovićDepartment of Science, Institute for Information Technologies, University of Kragujevac, Jovana Cvijića bb, 34000 Kragujevac, Serbia.ORCID 0000-0002-8833-8035
Ivan PotočňákInstitute of Chemistry, P. J. Šafárik University in Košice, Moyzesova 11, 04154 Košice, Slovakia.
Erika SamoľováInstitute of Physics of the Czech Academy of Sciences, Na Slovance 2, 182 21 Prague 8, Czech Republic.
Milena S DimitrijevićDepartment of Life Sciences, Institute for Multidisciplinary Research, University of Belgrade, Kneza Višeslava 1, 11030 Belgrade, Serbia.ORCID 0000-0003-1659-5945
Luciano SasoDepartment of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.ORCID 0000-0003-4530-8706
Zoran S MarkovićDepartment of Science, Institute for Information Technologies, University of Kragujevac, Jovana Cvijića bb, 34000 Kragujevac, Serbia.
Jasmina M Dimitrić MarkovićFaculty of Physical Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia.
University of Kragujevac · RSUniversity of Belgrade · RSCzech Academy of Sciences · CZMerseburg University of Applied Sciences · DESapienza University of Rome · ITUniversity of Pavol Jozef Šafárik · SK

Funding

Ministry of Education, Science and Technological Development of the Republic of Serbia 451-03-9/2021-14/200378, 51-03-09/2021-14/200122, and 451-03-68/2020-14/200146Operation program Prague Competitiveness CZ.2.16/3.1.00/24510Science Fund of the Republic of Serbia (Serbian Science and Diaspora Collaboration Program: Knowledge Exchange Vouchers) TumorSelCoum 6388843Slovak grant agencies VEGA 1/0148/19.
6 · The paper itself

Abstract

In this contribution, four new compounds synthesized from 4-hydroxycoumarin and tyramine/octopamine/norepinephrine/3-methoxytyramine are characterized spectroscopically (IR and NMR), chromatographically (UHPLC-DAD), and structurally at the B3LYP/6-311++G*(d,p) level of theory. The crystal structure of the 4-hydroxycoumarin-octopamine derivative was solved and used as a starting geometry for structural optimization. Along with the previously obtained 4-hydroxycoumarin-dopamine derivative, the intramolecular interactions governing the stability of these compounds were quantified by NBO and QTAIM analyses. Condensed Fukui functions and the HOMO-LUMO gap were calculated and correlated with the number and position of OH groups in the structures. In vitro cytotoxicity experiments were performed to elucidate the possible antitumor activity of the tested substances. For this purpose, four cell lines were selected, namely human colon cancer (HCT-116), human adenocarcinoma (HeLa), human breast cancer (MDA-MB-231), and healthy human lung fibroblast (MRC-5) lines. A significant selectivity towards colorectal carcinoma cells was observed. Molecular docking and molecular dynamics studies with carbonic anhydrase, a prognostic factor in several cancers, complemented the experimental results. The calculated MD binding energies coincided well with the experimental activity, and indicated 4-hydroxycoumarin-dopamine and 4-hydroxycoumarin-3-methoxytyramine as the most active compounds. The ecotoxicology assessment proved that the obtained compounds have a low impact on the daphnia, fish, and green algae population.

Indexed as

4-HydroxycoumarinsAntineoplastic AgentsCarbonic AnhydrasesCell Line, TumorCell ProliferationCell SurvivalHCT116 CellsHeLa CellsHumansMolecular Docking SimulationMolecular Dynamics SimulationMolecular StructureNeoplasmsNeurotransmitter AgentsOctopamineX-Ray Diffraction4-HydroxycoumarinsAntineoplastic AgentsCarbonic AnhydrasesNeurotransmitter AgentsOctopaminecoumarinDFTmolecular dockingmolecular dynamicsneurotransmitterX-ray crystallography

Identifiers

PMID35055194
PMCPMC8780855
OpenAlexW4205292047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.